Ammar Al-Chalabi | |
---|---|
Education | |
Known for | Research on amyotrophic lateral sclerosis |
Awards | Sheila Essey Award from the American Academy of Neurology (2016) |
Scientific career | |
Fields | |
Institutions | King's College London |
Thesis | Genetic risk factors in amytrophic lateral sclerosis (1999) |
Academic advisors | Nigel Leigh |
Ammar Al-Chalabi is Professor of Neurology and Complex Disease Genetics at the Maurice Wohl Clinical Neuroscience Institute at King's College London, where he is also head of the Department of Basic and Clinical Neuroscience and Director of the King's Motor Neuron Disease Research Centre. In 2020, he received the Forbes Norris Award from the International Alliance Of Als/Mnd Associations and was a co-winner of the Healey Center International Prize for Innovation in ALS. His other awards include the Sheila Essey Award from the American Academy of Neurology and the Charcot Young Investigator Award from the Motor Neurone Disease Association.[1][2] In 2021 he was appointed Senior Investigator at the National Institute for Health Research (NIHR).[3]
References
- โ "Ammar Al-Chalabi". Maudsley BRC. Retrieved 2021-02-20.
- โ "Professor Ammar Al-Chalabi receives Forbes Norris Award". King's College London. Retrieved 2021-02-20.
- โ "NIHR appoints Senior Investigators for 2021". www.kcl.ac.uk. Retrieved 2022-01-04.
Further reading
- Morgan, Jules (May 2017). "Ammar Al-Chalabi: from complex genetics to acoustic rock". The Lancet Neurology. 16 (5): 347. doi:10.1016/S1474-4422(16)30305-2. PMID 27818158. S2CID 33459416.
External links
- Faculty page
- Ammar Al-Chalabi publications indexed by Google Scholar